Pricing Log in Create free account
Friday 6 November 2026 Export ABT’s income statement to Excel — free account

Abbott Laboratories

ABT Healthcare Medical Devices

Abbott Laboratories' revenue for fiscal 2025 (year ended December 2025) was $44.3 billion, up 5.67% from fiscal 2024.

Revenue
+14.5%
EPS
−43.6%
Free cash flow
+28.9%
Total debt
+142.7%

Quarter to September 2026, against a year earlier

110.32 3.28 −2.89%
Market cap
$196.6B
P/E
42.3×
Fwd P/E
35.1×
Dividend yield
2.22%
F-score
5/9
Altman Z
5.61
Beneish M
−2.50
Dividend safety
62/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Abbott Laboratories (ABT) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, Abbott Laboratories (ABT) trades at a EV/EBITDA of 20.8×. Over the past ten years it has ranged from 12.1× (September 2015) to 29.5× (August 2020); the current reading is higher than 59% of that period. That is above the Medical Devices industry median of 11.5× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 19.9× (1.60%)
FY2024 20.2× (1.05%)
FY2023 20.4× 19.53%
FY2022 17.1× (20.66%)
FY2021 21.5× (9.01%)
FY2020 23.7× 6.70%
FY2019 22.2× 8.38%
FY2018 20.5× (6.57%)
FY2017 21.9× 67.03%
FY2016 13.1× (14.99%)

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 18.4× 7.61%
Jun 2026 17.1× (9.44%)
Mar 2026 18.9× (4.85%)
Dec 2025 19.9× (9.60%)
43 more quarters

Against its own ten years

Low 12.1× High 29.5×
Ten-year median 20.3×
Current reading's percentile 59

EV/EBITDA against peers

Company EV/EBITDA
PHG Koninklijke Philips N.V. compare 11.1×
GEHC GE HealthCare Technologies Inc. compare 13.2×
BSX Boston Scientific Corporation compare 14.0×
STE STERIS plc compare 15.7×
MDT Medtronic PLC compare 15.7×
ABT Abbott Laboratories 20.8×
SYK Stryker Corporation compare 21.0×
DXCM DexCom, Inc. compare 21.2×
EW Edwards Lifesciences Corporation compare 34.0×
Medical Devices industry median 11.5×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on ABT